GMDTC for injection

DRUG3 trials

Sponsors

Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd., Guangdong Jianersheng Pharmaceutical Technology Co., Ltd.

Conditions

Cadmium Exceeds the StandardCadmium Exposure

Phase 1

Safety Study of GMDTC Injection in Healthy Participants

CompletedNCT05908383

Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.Cadmium Exposure

Start: 2023-01-30End: 2023-07-30Updated: 2024-01-02

Safety Study of GMDTC Injection in Participants With Excessive Cadmium

CompletedNCT06199349

Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.Cadmium Exceeds the Standard

Start: 2024-01-08End: 2024-12-05Updated: 2025-02-20

Phase 2

The Safety and Efficacy of GMDTC for Injection in Subjects With Elevated Cadmium Levels

RecruitingNCT07057414

Guangdong Jianersheng Pharmaceutical Technology Co., Ltd.Cadmium Exceeds the Standard

Start: 2025-07-07End: 2025-12-30Target: 11Updated: 2025-09-02